6 completed. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Da Volterra: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI) DAV132 - Clostridium Difficile Infection | Not applicable | Completed | Da Volterra | 260 | 2018-10-31 | 2019-08-30 |
| COMBACTE-CDI Understanding the Burden of C. Difficile Infection No intervention - Clostridium Difficile Infection | Completed | University of Leeds | 3240 | 2018-06-11 | 2022-02-09 | |
| AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment no intervention - Clostridium Difficile | Completed | MJM Bonten | 1007 | 2016-09-27 | 2021-05-21 | |
| Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers Moxifloxacin, DAV132, Negative control - Healthy Subjects | Phase 1 | Completed | Da Volterra | 150 | 2016-05-11 | 2017-09-12 |
| Safety and Efficacy Study of DAV132 in Healthy Volunteers DAV132, Moxifloxacin, Negative Control - Healthy | Phase 1 | Completed | Da Volterra | 44 | 2014-03-01 | 2020-02-28 |
| Multi-Antibiotic Resistance Carriage in Gut Flora Intestinal Bacteria Flora Disturbance | Completed | Da Volterra | 272 | 2012-03-01 | 2014-05-29 |
Moxifloxacin (2)
France (4) · Germany (2) · Romania (2) · Bulgaria (1) · Greece (1) · Netherlands (1) · Serbia (1) · Spain (1) · United Kingdom (1)
Marc Bonten, MD, PhD (1) · Mark Wilcox, MD (1) · Xavier Duval, MD (1) · Yves Donazzolo (1)